Language selection

Search

Patent 1225954 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1225954
(21) Application Number: 1225954
(54) English Title: PROCESS FOR THE PREPARATION OF CEPHEM COMPOUNDS
(54) French Title: PREPARATION DE COMPOSES DE TYPE .beta.-LACTAME
Status: Term Expired - Post Grant
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12P 35/02 (2006.01)
  • C07D 50/18 (2006.01)
  • C12P 35/08 (2006.01)
(72) Inventors :
  • LATTRELL, RUDOLF (Germany)
  • DURCKHEIMER, WALTER (Germany)
  • KIRRSTETTER, REINER (Germany)
  • SCHWAB, WILFRIED (Germany)
(73) Owners :
  • HOECHST AKTIENGESELLSCHAFT
(71) Applicants :
  • HOECHST AKTIENGESELLSCHAFT (Germany)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued: 1987-08-25
(22) Filed Date: 1984-05-04
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
P 33 16 796.6 (Germany) 1983-05-07

Abstracts

English Abstract


HOE 83/F 079
Abstract of the disclosure:
Process for the preparation of cephem compounds
Process for the preparation of 7-amino-cephalos-
poranic acid derivatives of the formula
<IMG>


Claims

Note: Claims are shown in the official language in which they were submitted.


- 39 -
THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the preparation of a 7-amino-cepha-
losporanic acid derivative of the formula I
<IMG>
wherein
R1 denotes hydrogen or methoxy and
A denotes a pyridinium radical <IMG> , which
can be monosubstituted or polysubstituted by iden-
tical or different substituents from the group
comprising optionally substituted C1-C6-alkyl,
it being possible for two alkyl groups in the or-
tho-position also to be linked to form an optio-
nally substituted di- to deca-methylene ring, in
which one ring carbon atom can be replaced by a
heteroatom and which can furthermore also con-
tain one or two double bonds, optionally substi-
tuted C2-C6-alkenyl, C2-C6-alkinyl and
C3-C7-cycloalkyl and C3-C7-cycloalkyl-methyl,
it being possible for the ring also to be substi-
tuted in the last two substituents; C4-C7-cyclo-
alkenyl, optionally substituted C1-C6-alkoxy,
C2-C6-alkenyloxy and C2-C6-alkinyloxy, halo-
gen, trifluoromethyl and hydroxyl, and optionally

- 40 -
substituted phenyl, benzyl and heteroaryl, and
wherein, furthermore,
A denotes a quinolinium or an isoquinoli-
<IMG>
nium <IMG> radical, each of which can also
be monosubstituted or polysubstituted by identi-
cal or different substituents from the group com-
prising optionally substituted C1-C6-alkyl,
C1-C6-alkoxy, halogen, trifluoromethyl and
hydroxyl, which comprises reacting a compound of
the general formula II, or salts thereof,
<IMG> (II)
in which
R1 denotes hydrogen or methoxy,
R2 denotes a group which can be replaced by the
base corresponding to the radicals A of formula I,
and in which R3Co- represents an acyl radical,
with the base on which the radical A defined above in for-
mula I is based, to form the compound of the general for-
mula II
<IMG>
(III)
in which
A, R1 and R3 have the abovementioned meaning,

- 41 -
and then splitting off the acyl radical by general chemi-
cal or enzymatic methods known from cephalosporin and
penicillin chemistry, to form the compound I.
2. A process as claimed in claim 1, wherein the radi-
cal R3Co- is a formyl radical or an acyl radical known
from cephalosporin and penicillin chemistry.
3. The process as claimed in claim 2, wherein the
radical R3Co- is a thienylacetyl, phenylacetyl or phen-
oxyacetyl radical or the radical NH2-<IMG>(CH2)3CO-
the functional groups of which can be protected.
4. The process as claimed in claim 1,
wherein the reaction with the base corresponding to the
substituent A is carried out in the presence of a tri-C1-
C4-alkyliodosilane.
5. The process as claimed in claim 4, wherein the
tri-C1-C4-alkyliodosilane is trimethyl- or triethyl-
iodosilane.

Description

Note: Descriptions are shown in the official language in which they were submitted.


L2Z595~
-- 2 --
HOE 83/F 079
The invention relates to a process for the pre-
~ parat;on of 7-amino-cephalosporanic acid derivatives of
; the general formula I
R1
H2N
l (I)
o ,~ ~ CH 7,A
co2e
S- wherein
R1 ~denotes hydrogen or methoxy and
A denotes a pyridlnium rad7cal 0 N ~ , ~hich
can be monosubstituted or polysubstituted by
identical or different substituents;from the group
~10 ~ compr;sing opt;onally subst;tuted C;-C6-alkyl, it
`bei~ng possible for two alkyl groups in the ortho-
; ~ pos;tion also to be llnked to form an optionally
~ subststuted di- to deca-methylene ring, in which
; ~ one ring carbon atom can be replaced by a hetero-
atom and wh;ch can furthermore also contain one
or two double bonds, optionally substituted C2-C6-
alkenyl, C2-C6-alk;nyl and C3-C7-cycloalkyl and
:
C3-C7-cycloalkyl-methyl, it being possible for the
ring also to be subst;tuted in the last two sub-
stituents; C4-C7-cycloalkenyl, optionally substi-
tuted C1-C6-alkoxy, C2-C6-alkenyloxy and C2-C6-
` alkinyloxy, halogenr trifluoromethyl and hydroxyl,
.. .
~r~
~4
.

,~ ~LrZ2~;i9~i4
- 3 -
and optionally substituted phenyl, benzy1 and
heteroaryL, and where;n, furthermore,
A denotes a quinol;nium ~ or an isoquinol;-
n;um - ~ ~ rad;caL, each of which can also
be monosubstituted or polysubstituted by identi-
cal or different substituents from the group com-
prising opt;onally substituted C1-C6-alkyl, C1-C6-
alkoxy, halogen, trifLuoromethyl and hydroxyl.
The present invention particularly relates to com-
pounds in wh;ch A denotes a pyr;d;nium rad;cal - ~ ,
which can be monosubstituted or polysubstituted by iden-
ticai or different substituents from the group compris-
; ;ng C1-C6-alkyl, which can be monosubstituted or poly-
~ s~u~bsti~tuted~by hydroxyl or sulfo; and C1-C6-alkoxy and
h;ydroxy-C1-C6-aLkoxy, it being possible ~or two alkyl
gr;oups also ~o be~linked to form an optiona~lly substitu-
~ted di~-`to de~ca-m~ethylene ring, in which one ring carbon
; atom can be replaced by a heteroatom and which can fur-
:
thermore~also contain one or two double bonds,
C2-C6-alkenyl, which can be substituted by hydroxyl,
C2-C6-alkinYl~
C3-C7-cycLoalkyl and C3-C7-cycloaLkyl-methyl, it being
poss;bLe for the ring also to be subst;tuted by hydroxyl
or halogen in these two substituents,
C4-C7-cycloalkenyl,
C1-C6-alkoxy~ which can be substituted by hydroxyl,
C~-C6-alkenyloxy and c2-c6-alk;nYloxy,
halogen, ~r;fluoromethyl and hydroxyl, and phenyl, benzyl
..
.
'

Z2S~3$~
-- 4 --
or heteroaryl, wh;ch can also be subst;tuted by halo~en,
or in which A denotes a qu;nol;n;u~ or ;soquinolinium
rad;cal, each of which can also be monosubstituted or
polysubstituted by identical or different substituents
from the group compris;ng C1-C6-alkyl, wh;ch can be sub-
st;tuted by hydroxyl, and c1-C6-alkoxy, halogen, tr;flu-
oromethy~ and hydroxyl.
- ~ossible optional substituents of the di- to deca-
methylene ring mentioned under A, in which one ring car-
bon atom can be replaced by a heteroatom and which can
furthermore also contain one or two double bonds, are, ;n
; part;cular, the follow;ng substituents, wh;ch may occur
singly or in combinat;on, but preferably singly: C1-C6-
; alkyl, C1-C4-alkoxy, hydroxymethyl, halogen, hydroxyl, oxo
and exome~thylene.
These substituents can occur on the above rings
fused ont~o the pyridinium rad;cal, ;ndependently of whe-
t~her the particular ring is saturated, unsaturated or
also ;nterrupted by a heteroatorn.
The ring fused onto the pyridinium radical can
contain two to ten r;ng members Sd;- to deca-methylene),
but preferably three to five ring members, and thus is,
for example, a cyclopenteno, cyclohexeno or cyclohepteno
ring. lf such a fused-on ring contains a double bond,
examples which may be mentioned are the dehydrocyclopen-
tadieno, dehydrocyclohexadieno and dehydrocycloheptadieno
r;ng. If one carbon atom ;n such a r;ng is replaced by a
heteroatom, poss;ble heteroatoms are, ;n particular~ oxy-
:
~ gen or sulFur. Examples wh1ch may be mentioned of fused-on
.

2~i954
- 5 -
r;ngs wh;ch contain an oxygen atom and two or one doubLe
bond are furo, pyrano, dihydrofuro and dihydropyrano;
examples of fused-on rings containing a sulfur atom and
t~o or one double bond are thieno, thiopyrano, dihydro-
thieno and dihydropyrano. Of the fused-on rings contain-
;ng a~heteroatom, those rings wh;ch contain only one
double bond are particularly suitable for subst;tution,
especially by the abovementioned substituents.
The following substituents are examples of parti-
cularLy pre~erred substituents:
A: a quinolinium or an ;soquinolinium radical, each of
~h;ch can also be monosubstituted or polysubstituted
-,
by identical or d;fferent substituents from the group i
compri~slng C1-C6~alkyl, such as, for exampLe, methyl,
.
ethyl and propyl, preferably methyl, methoxy, hydroxyl,
halogen and tr;fluoromethyl, or a pyridinium radical,
~hich can be~monosubstituted or polysubstituted, pre-
ferabLy mono-, di- or tr;-substituted, in particular
~ mono- or~ di-s~ubstituted, for example by C1-C4-alkyl,
such as, in particular, methyl, ethyl, propyl, isopro-
pyl, n-butyl, sec.-butyl, tert.-butyl, dim~thyl, tri-
methyl, methyl and etbyl, methyl and propyl, methyL
and isopropyl or ethyl and ethyl; or hydroxy-C1-C4-
~ alkyl, such as, i~n particular, hydroxymethyl, hydroxy-
ethyl, hydroxypropyl, hydroxyisopropyl, hydroxybutyl,
hydroxy-sec.-butyl or hydroxy tert.-butyL~ it also be~
;ng possible, for example, for the alkyl radical to
carry two or three hydroxyl groups; C3-C4-alkenyl,
such as, ;n part;cular, allyl~ 2-methallyl and buten-
.
~ '
,.

;9~;4
-- 6 --3-yl, which can also be substituted by hydroxyl, such
as, in part;cular, hydroxyallyl and hydroxybutenyl;
C3-aLkinyl, such as, in particular, propargyl~ C3-C6-
cycloalkyl or C3-C6-cycLoalkyl-methyl, the carbon num-
ber relat;ng to the cycloalkyl part, such as, in par-
ticular, cyclopropyl, cyclobutyl, cyclopentyl, cyclo
hexyl and cyclopentylmethyl, it be;ng possible for the
r;ngs also to be subst;tuted, for example by hydroxyl,
such as, in particular, 1-hydroxy-cyclopentyl and 1-
hydroxy-cyclohexyl, or by halogen, preferably chlorine;
C5-C6-cycloalkenyl, such as, ;n particular, cyclo-
penten-1-yl and cyclohexen-1-yl;
C1-C6-alkoxy, such as, in particular, methoxy and eth-
oxy;
halogen, such as, in particular, 3-fluoro, 3-chloro,
3-bromo or 3-iodo; hydroxyl, in particular 3-hydroxyl;
tr;fluoromethyl, in part;cular 3-~rifluoromethyl; phe-
nyl and benzyl, which can also be subst;tuted, for ex-
ample by halogen, in particular chlorine, such as, for
example, 4-chlorobenzyl; or Z'-th;enyl or 3'-thienyl.
If A is a pyridinium radical which is substitu-
ted by two alkyl groups linked to form a di- to deca
methylene ring which can ;n turn be monosubstituted or
polysubst;tuted, preferably monosubstituted, and can con-
ta;n one or two double bonds, the following fused~on ringsystems are very particularly suitable here:
cyclobuteno, cyclopenteno, hydroxycyclopenteno, oxocyclo-
penteno, hydroxymethylcyclopenteno, exomethylenecyclopen-
teno, carboxycyclopenteno and carbamoylcyclopenteno,
,

` ~2~:;95
-- 7 --
cyclohexeno, hydroxycyclohexeno, oxocyclohexeno, hydroxy-
methyl-cyclohexeno, exomethylene-cyclohexeno, carboxycyclo-
hexeno and carbamoylcyclohexeno,
cyclohepteno, hydroxy-, oxo-, hydroxymethyl-, exomethyl-
ene- and carboxy~cyclohepteno and carbamoylcyclohepteno;
and dehydro-cyclopenteno, dehydro-cyclohexeno and dehydro-
cyc lohepteno.
If a ring carbon atom in the abovement;oned fused-
on ring systems is replaced by a heteroatom, in particu-
lar oxygen, the foliowing ring systems are particularlysultable: furoC2,3-b]pyridine, furo~3,2-b3pyridine, furo-
C2,3-c~pyridine, furo~3,2-c]pyridine, thieno~2,3-b]pyrid-
;ne, th;eno~3,2-b]pyrid;ne, th;eno~2,3-c3pyridine, thieno-
C3,2-c3pyridine, thieno~3,4-b3pyr;d;ne and th;eno~3~4~c3-
pyrid;ne.
The process according to the ;nvention for thepreparat;on of compounds of the formula I comprises reac-
ting a compound of the general formula II, or salts thereof,
R1
R3CONIl = ,~S
~:H2R ~II)
COO~ .
wherein
R1 denotes hydrogen or methoxy,
R2 denotes a group which can be replaced by the
base corresponding to the radicals A of formula I,
~. 7
and in which RJC0 represents an acyl radical, for
example a formyl radical or an acyl radical which
is generally known from cephaLosporin and peni-
~` `f'
'' ' '

- 1~259S4
. - 8 -
cill;n chem;stry,
with the base on which the radical A defined above in for-
mul:a I is based, to form the compound of the general for-
mula III
~R1
R3CoN~I~5~
5 ~ o ~ ~ ( I I I )
in ~hich
~ A, R1 and R3 have the abovement;oned meaning,
and then spl;tt;ng off the acyl radical by general chemi-
cal or enzymatic methods known from cephalosporin and
:
penicillin chemistry, to form the compound I.
: Particularly su;table radicals R2 are acyLoxy
: radicaLs of lower aliphatic carboxylic acids, preferablywith 1 tD 4 carbon atoms, such as, for example, acetoxy
or propionyloxy, in particular acetoxy, which can opt;on-
; 15 ally be substituted, such as, for example, chloroacetoxy
or acet~o~acetoxy. Other ~roups are aLso suitable for R2,
such as, for example, carbamoyloxy.
In the acyl radicals R3Co-, R3 denotes hydrogen or
the group R4-~CH2)n-, in which n = O or 1 and R4 denotes
` 20 a C~-C1û-alkyl radical, preferably a C1-C4-alkyl rad;-
caL, whlch can be monosubstituted or polysubstituted by
identi~cal or different substituents from the group com-
`pr;sing optionally substituted carbocyclic or heterocyc~
I;c aryl, such as, for example, phenyl and thienyl, opti-.
onally substituted aryloxy or heteroaryloxy, such as~ for
example, phenyloxy, optionalLy substituted arylthio or

:. ~l225954
_ 9 _
heteroarylthio~ such as, for example, phenylthio and imi~
dazolylthio, C3-C6-cycloalkyl and C4-C~-cycloalkenyl, op~
tionally subst;tuted c1-c6-alkoxY, opt;onally subst;tu-
ted Cl-c6-alky~thio~ cyano, haLogen, trifluoromethyl, sul-
fo, hydroxyl, amino and carboxyl, it being possible forhydroxyl, am;no and carboxyl groups also to be protected
or blocked, for example the group
, 2 3 '
CO01~
;n which Z represents optionally substituted arylcarbonyl,
such as, for example, phenylcarbonyl or heteroarylcarbonyl,
such as, for example, th;en-2-yl-carbonyl, opt;onally sub-
stituted C1-C4-alkoxycarbonyl or the group
; -CH=C(C02C2H5)~, opt;onally subst;tuted C1-C6-alkyl-sul-
fonyl or opt;onally subst;tuted phenylsulfonyl, such as,
for example, 4-methyl-phenylsulfonyl or 4-chloro-phenyl-
sulfonyl, or R4 denotes an opt;onally substituted car-
bocycl;c or heterocyclic aryl radical, such as, for ex-
ample,~phenyl, th;enyl or furyl.
R3 furthermore denotes the group R4-C~
~oR5
wherein RS denotes hydrogen or an opt;onally subst;tu-
ted C1-C6-alkyl rad;cal and R4 has the above mening,
or R3 denotes the rad;cal R6CO-~C,- , in which R6 de-
oR5C1-C6-alkyl~
Particularly preferred starting compounds are
those in which the acyl radicals R3Co- denote a thienyl-
acetyl or phenylacetyl radical whictl can be split off

~225~5
- 10 ~
enzymatically by means of pen;c;llin G am;dohydrolase.
Start;ng compounds wh;ch are readily access;ble preparat-
ively and are thus inexpensive and in which R3Co- can be,
for example, thienylacetyl~ phenylacetyl or phenoxyacetyl
S are also preferred. The radicals of the natural product
cephatosporin C and blocked and protected derivatives
thereof, of the formula Z-NH-CH~CH2)3 CO-, in wh;ch
COOH
Z has the abovementioned meaningy are furthermore parti-
cularly preferred. The startiny compounds are thus known
from the literature or can eas;ly be prepared by proces-
ses which ire known from the literature.
The react;on of compounds of the general formula
II w;th the bases which correspond to the radicals A ;n
the general formula I can be carried out in water or in
~a mixture of water and a readily water-m;scible organ;c
solvent, such as, for example, acetone, d;oxane, aceto-
~nitrile, d;methylformam;de, dimethylsulfoxide or ethanol.
::
The reac~t;ion temperature ;s ;n general in the range from
about 10~to about 100C, and is preferably between 20 and
80C. The base ComponQnt is added in amounts between
approximately equimolar amounts and up to a 5-fold excess.
Replacement of the radical R2 is facilitated by the pre-
sence of neutral salt ;ons, preferably of iodide or thio-
cyanate ions, ln the reaction medium. In particular,
about 10 to about 30 equivalents of potassium iodide~
sodium iodide, potassium thiocyanate or sodium thiocyanate
are added. The reaction is advantageously carried out
close to ~he neutral po;nt, preferably at a pH value in the
~ ~ . . . . .
,

f` ~ 9S4
- 11 -
range from about 5 to about 8~
The react;on can also preferabLy be carried out
;n non-aqueous solut;on ;n the presence of tr;-C1-C4-alkyl-
. iodosilane, such as, for example, trimethyl- or triethyl-
;odos;lane. The react;on of compounds of the general for-
mula II with pyr;d;ne bases ;s known. Thus, for example,
it is reported in the literature tEuro~pean Patent 60,144)
that 3-iodomethyl-cephalosporin deriva~ives, for example
compounds wh;ch correspond to those of the formula I,
1û ~here A - I, react with pyridine bases to give the corre-
spond;ng pyridinium compounds. Such iodoalkyl compounds
can generally be prepared from esters, for example acet-
ates, wlth trimethyliodosilane (J. Amer. Chem. Soc. 99,
968, 1977; and Angew. Chem;e 91, 648, 1979)~ a reaction
wh;ch has~subsequently been applled to cephalosporins
(European Patent 34,924, U.S. Patent 4,266,049, Tetra~
hedron Letters 1981, 3915 and European Patent 70,706).
According to the two-stage process described in
European~Patent 60,144, for example, the acetates corre
2a sponding to those of the forwuLa II (R2=OCOCH3) are first
converted into the 3-iodomethylcompounds, and these are
;solated and then reacted with the desired pyridine bases.
Purification by chromatography is necessary to isolate
the end products, and the maximum yield of pure end product
is below 10% o~ theory. Even in a var;ant described in
European Patent 70,706, Example 5, in which the 3-iodo-
methyl compounds are not isolated, after reaction with
pyridine, the title compound, besides several components~
can be identified only by chromato~raphy.

2S9S~
- 12 -
It is surprising that the yields of end products
of the formula I are ;ncreased up to more than ten-fold
~hen the nucleoph;l;c replacement react;on ;s carried out
from the start ;n the presence of an excess of the corre-
sponding bases on which the radical A in formula I is based,i.e. a tr;-C1-C4-alkyl;odos;lane, preferably trimethyl-
iodos;lane~ after addition of the base to the react;on
mixture.
The process ;s carr;ed out by a procedure in which
the base corresponding to the rad;cal A ;s added to a
solut;on or suspension of the compound II ;n a suitable
solvent, followed by tr;methyliodosilane. It is also
poss;ble, for example, for a reaction mixture of iodine
and~hexamethyldisilane, which have first been reacted at
temperatures between about 60 and 1Z0C in a manner
known from the L;terature, tr;methyl;odos;lane being
formed, to be used instead of trimethyliodosilane. In-
stead of trimethyliodosilane, triethyl;odosilane which
has been prepared in a manner which is known from ~he
literature can also be used with the same good results.
The reaction ;s carried out at temperatures between about
-S and ~100C, preferably between +10 and t80C.
Examples of su;table inert aprotic solvents are
chlorinated hydrocarbons, such as methylene chloride~
chloroform, d;chloroethane, trichloroethane and carbon
tetrachlor;de, or lower alkyl-n;tr;les, such as aceton;t-
rile or propion;trile, or fr;gens; ;n part;cular, methyl-
ene chlor;de ;s an outstand;ng solvent.
At least the stoichiometric arnount up to a twenty-
' ' .

- ~.2Z595~
- 13 -
fold excess of the base corresponding to the radical A is
added, and the react;on ;s preferably carr;ed out with
amounts such that the quant;ty of hydrogen ;od;de l;ber-
ated ;s bonded and at least 1 mole, preferably 2-5 moles,
of the base are still ava;lable for the replacement reac-
tion~
Since, besides the group R2 to be replaced in the
start;ng compound II, other funct;onal groups present,
such as the am;no, carboxyl or am;de group, react w;th
trimethyl~iodos;lane, the latter ;s added ;n at least a
four-fald up to a twenty-fold excess, preferably in a
f;ve- to ten-fold excess.
Carboxyl and N-am;no groups ;n the compound II
i can also be pres;lylated by add;t;on of a silylating
`15 agent,~such as, for example, b;strimethyls;lylacetam;de,
bistr;met~hylsilyltr;fluoroacetamide, trimethylchloros;l-
i
ane~, hexamethyldisilazane or bistrimethylsilylurea, eitherin the absence of or in the presence of a base, preferably
;the desired bsse on wh;ch the group A ;s based, in the
amount descr;bed above. At least the stoichiometr;c amount
or an excess of tr;methyl;odos;lane, preferably a two-
~ :
fold up to a ten-fold excess, is then added~
If the base on wh;ch the radical A in formula I
;s based contains funct;onal groups, such as, for example,
hydroxyl groups and the l;ke, these are preferably pre-
silylated with one of the abovementioned silylat;ng agents
and then used ;n tl1e react;on.
The reaction products of the formula III can be
isolated from the aqueous phase obtained by adding watcr
. ' .

5~354
- 14 -
or aqueous mineral ac;ds, for example d;lute HCl, HBr, HI
or H2S04~ in the customary manner, for example by freeze-
dry;ng the aqueous phase, chromatography and the l;ke~
The polar reaction products are preferably precipitated
from the aqueous soLut;on in the form of a sparingly sol~
uble salt, for example a hydr;od;de salt.
~ he acyl group R C0 in the result;ng compounds
of the generaL formula III iS then split off by generally
known chemical methods - for example by hydrolysis with
d;lute mineral ac;ds, such as, for example, hydrochlor;c
acid or sulfuric acid, or by imide chlorides - or enzym-
at;c methods, such as are described, for example, ;n
6erman Offenlegun~sschr1ft 3,019,838.
If imide chloride splitting is used, the compound
15 :~III ;s reacted with, for example, phosphorus pentachloride,
the imide chlor;de formed is converted into the imino-
ether by~addition of an alcohol and this ether is then
~split~by~hydrolysis~or alcoholysis. The reaction is ad-
vantageously carried out in the presence of a silylating
agent, such as trimethyLchlorosiLane. After hydrolysis
of the reaction mixture by addition of water, the compound
of the general formula I formed is isolated from the
aqueous p;hase in the customary manner, for example by
freeze-drylng or chromatography over silica gel or the
like~ The~rea~ction products are preferably isolated from
the reaction solution directly as spar;ngly soluble salts,
for exampLe a hydrochloride or hydr;od;de~
If enzymatic splitting is used, for example, the
acyl radical in compounds of the formula III in which

X~i9S4
- 15 -
R3co denotes C6H5CH2CO- or ~ ~ c~ CO_ is spljt off
with fixed penicillin G am;dohydrolase. The reaction is
carried out ;n aqueous solut;on at a temperature of about
25-40C, preferably 35-37C, and a pH value of about
6.5-8.0, preferably 7~2-7.8. The pH value ;s kept con-
stant-by addition of 1 N NaOH. When the react;on has
ended, the f;xed enzyme ;s separated off by filtration.
The react;on products of the formula I thus ob-
tained are ;solated from the aqueous phase ;n the custom-
ary manner, for example by freeze-drying, chromatography
or precip;tation in the form of a spar;ngly soluble salt.
The compounds of the formula I according to the
~;nvent;on are starting substances for the preparation of
numerous h;ghly act;ve ant;b;ot;cs of the general formula
1~5 III' ~ R1
R CO-l~H ~--~S ~
o) ~ ~ 2
C2 ( I I I ' )
in wh;ch, for example, R1 denotes hydrogen or methoxy and
`~' R3 CO denotes, ;n part;cular, a 2-(aminoheterocyclyl)~2-
~ oxy;m;noacetyl radical, for example the 2-~2-aminothia-
zolyl~-2-oxyimino-acetyl radical, which are described in
German Patent Applications corresponding to German Offen
legungsschrift 3,118,732, P 32 07 840.4, P 32 47 614.0
and P 32 47 613.2~
~` The following embodiment examples for the com-
pounds which can be prepared by the process according to
the invention serve to further illustrate the invention,
.
'' '

.~ 2S9~L
- 16 -
but do not restrict it thereto.
Preparation of the starting materials
Example 1
3-[(2 3-C clo enteno 1- ; erid;n;o)methYl]-7-(2~th;enyl)~
,~ Y P _P P
acetalnido)-ceph-3-em-4 carboxylate
Variant a
A mixture of 150 g (0036 mole).of sod;um 7-t2
thienylacetamido)-cephalosporinate ~cephalothin), 680 g
(7 moles) of potasslum thiocyanate, 66.5 g (65 rnl, 0.56
mole) of 2,3-cyclopentenopyr;dine, 150 mL of water and
30 g of 85 per cent strength phosphoric acid ;s stirred
at 66-68C for 4 hours. During this time, the pH value
drops from 6.6 to pH 6Ø The yellow-colored viscous
solution is diluted with 3 liters of water and extracted
wlth ~our 400 ml por~ions of methylene chloride. 110 ml
of 18 per cent strength hydrochloric acid are then added
dropwise at 5-10C in the course of 30 mlnutes, wh;le
cooling and stirring, whereupon a voluminous precipitate
forms. The mixture is left in an ice-bath for 2 hours
and the precipitate is filtered off with suction, washed
w;th three 500 ml portions of water and dried in vacuo.
~-~ Yield: 130 g (0.245 mole) of light yellow-colored crys-
tflls (68X of theory) of decomposition point
156-1 58C.
C22H21N34S2 x HSCN x H20
Calculated C 51.86 H 4.54 N 10052 S 18.06 H20 3.38%
Found C 51.8 H 4.3 N 10.2 S 18.0 H20 2.9 %
IR (KBr): 1775 ~lactam C0); and 2040 cm 1 (SCN)
H-NMR (CF3C02D): S = 2.3-2.8 (m, 2H, cyclopentene H);

2S~3~;4
- 17 -
3.15-3.95 (m, 6H, 4 cyclopentene H
and SCH2); 4.06 ts, 2H, CH2CO);
5.2-6.2 (m, 4H, CH2Py and 2
lactam H); 6.8-7.4 (m, 3H, th;o-
phene) and 7.65-8.70 ppm ~m, 3H,
PY).
Varlant b
3.96 9 (10 mmol) of 7-(2-thienylacetamido)-cepha-
losporanic acid are dissolved in 90 ml of methylene chlor-
ide, and 10.2 9 (10 ml, 86 mmol~ of Z,3-cyclopentenopyri-
dine are added. 14 g (10 ml, 70 mmcl) of trimethyliodo-
silane are then added dropw;se, while stirring and cool-
;ng, and the solution ;s heated under reflux for 2 hours.
It is cooled to -15C, 25 ml of 2 N hydrochlor;c acid
~: ~
are added and the organic phase is separated off. The
aqueous phase is adjusted to pH 6.0 by addition of sod;um
~bi~carbonate and ;s chromatographed over sllica gel (Grace,
~ : : : ~ ~ . : :
` 0.1 mm) us;n`g acetone:water (3:1). After freeze-drying
the pro~duct fractlons, the t;tle compound ;s obtained ;n
20~ the for~m~of a l;ght yellow amorphous solid. ~
Yield; 3.2 g (70.5% of theory) ~,
IR (KBr):~ 1775 cm~1 (lactam C0)
~MR `(CF3C02D): ~ - 2 .3-2.8 (m, 2H, cyclopentene H);
3.1-3.~5 (m, 6H, 4 cyclopentene H
and SCH2); 4.09 (s, 2H, CH2C0);
5.2-6.2S ~m, 4H, CH2Py and 2 lactam H);
6.8-7.4 (m, 3H, thiophene); and
7.65-8.85 ppm ~m, 3H, Py).
'` ', :
' " ' '
.
: '

S9~;4
~ 18 -
Example 2
3-C~2,3-Cyclopenteno-1-pyr;d;n;o)methyl~-7-phenylacetam-
ido-ce h-3-em-4-carboxylate
P
Vari ant a
The t;tle compound is obta;ned from 14.l~ g of
sod;urn 7-phenyLacetamido-cephalospor;nate, ~8 g of pot-
assium thiocyanate, 6.5 ml of 2,3-cyclopentenopyridine,
15 ml of water and 3.4 g of 85 ~er cent strength phospho-
ric acid analogously to Example 1a. The react;on m;xture
is diluted with 120 ml of acetone and chromatographed over
500 9 of silica gel (Grace, 0.1 mm) using acetone:water
(8:1) and then acetone:water (2:1). After freeze-drying,
the product fractlons give 7a5 g (48% of theory) of a
light grey-colored amorphous solid.
15 IR tKBr): 1770 cm 1 (lactam C0)
H-NMR (CF3C02D~: S = 2.25-2.85 (m, 2H, cyclopentene H);
3.1-3.75 (m, 6H, 4 cyclopentene H
and SCH2); 3.87 (s, 2H, CH2C0);
3.2-6.25 (m, 4H, CH2Py and 2 lac- ;
tam H); 7.38 (s, 5H, phenyl); and
`~`~ 7.6-8.7 ppm (m, 3H, Py).
~~ Variant b
The title compound is obtained from 3.9 g of 7-
phenylacetam;do-cephalosporinate, 10 ml of 2,3-cyclopen-
tenodpyridine and 10 ml of trimethyliodosilane ;n 90 mlof methylene chloride analogously to Example 1b. After
the hydrolys;s, the rnixture is chromatographed as above,
over silica gel using acetone:water (3:1).
Yield: 2.4 g (53.5%) of an arnorphous solid.

~L22~;9~i4
- 19 -
The compound is identicaL in all its properties
to that of Example 2a.
Examp le 3
,. 3-~(2r3-~enteno-1-pyridlnio)lnethyl]-7~phenoxy-
acetam;do~ceph-3-em-4-carboxylate
Var;ant a
The title compound is obtained~ from 21.4 g oF
sodium 7-phenoxyacetam;do-cephalosporinate, 95 g of pot-
ass;um thiocyanate, 9 ml of 2,3-cyclopentenopyr;dine and
1.5 g of 85 per cent strength H3P04 in 21 ml of water ana-
logously to Example 1a. After dilution with acetone, the
m;xture is chromatographed over 600 g of silica gel using
acetone:water (8-1) and then using acetone:water (2:1).
The product fractions are freeze-dried. 11.9 g (51% of
theory) of a colorless amorphous sol;d are obta;ned.
IR; ~KBr)~: 1770 cm 1 (la~ctam C0)
H-NMR ~CF3C02D): ~ = 2.25-2.85 ~m, 2H, cyclopentene H);
3.15-3.9 (m, 6H, cyclopentene H and
SCH2); 4.~31 (s,. 2H, CH2CO); 5.25-
6.20 (m, 4H, CH2Py and 2 lactam H);
: ;,
6.8-7.5 ~m, 5 phenyl H); and 7.65-
8.7 ppm (m, 3H, Py).
Var;ant b
The t;tle compound is obtained from 2.5 g of 7-
- 25 phenoxyacetamido-cephalospor;nate, S ml of 2,3~cyclopen-
tenopyridine and 5 ml of trimethyliodosilane ;n 45 ml of
methylene chlor;de analogously to Example 1b. After the
hydrolysis, the aqueous phase is chromatographed over
silica gel using acetone:water (3:1~ After freeze-drylng,

25g5
- 20 -
the product ~ractions give 1.8 g (61.5% of theory) of a
brown;sh-colored amorphous solid. The compound ;s iden-
ticaL in all its properties to that of Example 3a.
Example _
7-(D~5 B_ zam;do-5-carboxypentane-am;do)-3-rt2,3-cyclo~
Denteno-1-DYridinio)methyl]ceoh~3-em 4-carboxylate
Variant a
A solution of 5.2 g (10 mmol) of 7-tD-5-benzamido~
5-carboxypentane-amido)-cephalosporinate, 11.9 g (11~7 ml,
0.1 mole) of 2,3~cyclopentenopyridine, 66 g (0.4 mole) of
potassium iodide and 30 mg of ascorbic acid in 75 ml of
water and 25 ml of acetone is heated at 66-68C for 4
hours. After cooling, the mixture is diluted wi~h 500 ml
of acetone and chromatographed over 300 g of s;lica gel.
15 ~The sa~ts are eluted w;th acetone:water (7:1) and the
title~compound is eluted w~ith acetone:water t2:1). After
~freeze-drying of the product fractions, 3.2 g (55% of
theory) of a colorless amorphous solid are ob~ained~
IR (KBr): 1770 cm 1 (lactam C0)
1H-NMR (CF3C02D): ~ = 1.8-3.9 (m, 15H, 6 cyclopentene H,
SCH2 and pentane H); 4.8-602 (m~
4H, CH2Py and 2 lactam H); and 7.3-
8.7 ppm (m, 8H, Py and phenyl)0
Var;ant b
5.1 g ~4 ml, 28 mmol) of trimethyliodosilane are
added all at once to a mixture of 2.1 g (4 mmol) of 7- -~
(D-5-benzamido-5~carboxypentane aMido)-cephalospor;nate,
4.06 g (4 ml, 34 mmol) of 2,3-cyclopentenopyridine and
- 40 rnl of methylene chloride, wh1le cooling~ The mixture

- ~ ~Z2~i9~4
....~. - 21 - -
;s heated under reflux for 2 hours, cooled and hydrolyzed
by add;t;on of 5 ml of 2 N HCl. The aqueous phase ;s
separated off, adjusted to pH 6 with sodium bicarbonate
and chromatographed over 150 g of sil;ca geL using ace
tone:water (5:1) and then acetone:water (2:1~. After
~ freeze-drying, the produc~ fracti~ons give 1.9 g (47~5X of
; a light yellow amorphous solid. The compound is ;dent;-
cal in all its properties to that described above.
Example 5
7-tD-5-(4-Chlorobenzamido)~5-carboxypentane-amido)-3-
~(2,3-cyc~lopenteno-1-pyrid;nio)methyl]-ceph-3-em-4-car-
boxylate
Variant a
~The title compound is obtained as an amorphous
solid 1n 48% yield analogously to Example 4a from 5.5 g
t10 mmol) of 7-CD-5-(4 chlorobenzamido)-5-carboxypentane-
amido~-c~ephalosporinate, 11.9 9 (0.1 mole) of 2,3-c-yclo--
penten~opyridine, 66 g (0.4 mole) of potassium iodide and
30 mg of ascorbic acid in 100 ml of water:acetone (3:1).
.
20 IR (~Br): 1770 cm 1 (lactam C0)
H-NMR (CF3C02D): ~ = 1.9-2.9 (m, 8H, (CH2)3 and 2 cyclo-
pentene H); 3.1-3.8 (m, 7~, lt cyclo-
pentene H, SCH2 and CH); 4.9-6.3
(m, 4H, CH2Py and 2 lactam H); and
7.3-8.7 ppm tm, 7H, phenyl and Py).
Variant b
The title compound is obtained as an amorphous
sol;d analogously to Example 4b from 7-CD-5-~4-chlorobenz-
amido)-5-carboxypentane-arnido]-cephalosporinate, (Z.Z g),
.. .
.

-' ~ 2259S4
- 22
2,3-cyclopentenopyr;d;ne ~4.06 9) and tr;methyliodosilane
(5.1 g) ;n methylene chlor;de (40 ml), after chrorna-
tography. Yield: 51X of theory.
The compound is identical in all its propert;es
S to ehat described above.
The compounds of the following ~xamples 6~12 are
obtained from the correspond;ng cephalosporin derivatives
and 2,3-cycLopentenopyr;d;ne analogously to Example 4,
var;ant a ~replacement in water) or 4, variant b (tri-
methyliodosilane method).Example 6
7-(D-5-benzenesulfonamido)-5-carboxypentane-am;do)-3-
~(2,3-cyclopenteno-1-pyr;dinio~methyl]-ceph-3-em-4-car-
boxylate
Yield according to variant a. 45%, according to variant
b: 5ZX
.
1H-NMR (CF3C02D): ~ = 1.6-4.4 (m, 15H, 6 cyclopentene H,
- 7 pentane H and SCH2); 5.15-6.2
(m, 4H, CHzPy and 2 lactam H); and
7.4-8.65 ppm tm~ 8H~ phenyl and Py).
Example 7
7 CD-5-(4-MethylbenzenesuLfonamido)-5-carboxy-pentane-
amidoJ-3-~t2,3-cyclopenteno-1-pyridinio)methyl]-ceph-3-
em~4-carboxylate
Yield according to variant a: 38%
H-NMR tD6-DMS0): ~ = 1.2-4.1 tm~ 18H with s at 2.36-CH3,
6 cyclopentene H, 7 pentane H and
CH2S); 4.8~507 t4H, CH2 Py and
2 lactam H); and 7.2-9.4 ppm (~H,
.

~22~;95~
- 23 -
3 Py H, 4 phenyl H and 2NH).
7-~D-5~(4-chlorobenzenesulfonam;do)-5~carboxypentane
am;do~3-(2,3-cyclopenteno-1-pyridinio)methyl-ceph-3-em
4-carboxylate
~ rield according to variant a: 48%, accord;ng to variant
; b: 55%
H-NMR (CF3C02D): ~ = 1.6-4.4 ~m, 15H~ 6 cyclopentene H,
7 pentane H and SCH2); 5.1-6.25
(m, 4H, CH2Py and 2 lactam H); and
7.4-8.7 ppm (m, 7H, phenyl and Py)
Example 9
7-(D-S-Am;no~5-carboxy pentane-am;do-3-(2,3-cyclopenteno-
1-pyridinio)methyl-ceph-3-em-4-carboxylate
Yield (accord;ng to var;ant a): 19%
H-NMR (D2~0): ~ = 1.6-2.7 (m~ 8H, (CH2)3 and 2
cyclopentene H): 2.9-3.9 (m, 7H, 4
cyclopentene M; SCH2 and CH N); 5.9 5.95
(m, 4H, CH2Py and 2 lactam H); and 7~6-
8.7 ppm (m, 3H, Py)
Example 10
`- 7-(P-5-tert.-Butyloxycarbonylamino-5-carboxypentane-amido)-
3-t2,3-cyclopenteno-1-pyr;d;nio)methyl-ceph-3-em 4-car-
boxylate
Yield according to variant a: 15% of theory
H-NMR (D6-DMS0): ~ = 1.2-1.9 ~rn, 15H, ~CH2)3 and
C(CH3)3); 1.9-2.4 ~rn, 2 cyclo-
pentene H); 2.7-4.0 tln, 7H~ CHN,
SCH2 and 4 cyclopentene H); 4.~~
.

22S9~;A
-- Z4 --
5~7 (m, 4H, CHzPy and 2 lactam H);
6.0-6.3 (NH); 7.7-8.9 (m, 3H, Py):
and 9.1-9.4 ppm (NH)
Example 11
7-~(D-5-Carboxy-5-~2,2-diethoxycarbonyl)v;nylamino-pen-
tane-amido]-3-(2 3-cycLopenteno-1-pyridinio~methyl-ceph-
3-em-4-carboxylate
Yield accord;ng to variant a: 14X Of theory
1H-NMR ~D6-DMSO~: ~ = 1.0-1.4 (t, 6H, ethyl), 1.4-1.8
(m, 6H, (CHz)3); 1.9-2.4 tm, Z
cyclopentene H); Z.8-4.3 (m, 11H,
4 cyclopentene H), CHNH, SCH2 and 4
ethyl); 4.7-5.7 (4H~ CHzPy and 2
lactam H); and 7.6-9.8 ppm ~6H, 3
Py H, vinyl H~ 2 NH)
Example 12
7-t2 Acetyl-2-sYn-methoxyimino-acetam;do)-3-~2~3-cyclo-
penteno-1-pyridin;o)methyl-ceph-3-em-4-carboxylate
Yield according to variant a: 18% of theory
~ZO 1H-NMR (CF3C02D): ~ = 2.3-2.9 (m with s at 2n49~ 5H~
CH3CO and 2 cyclopentene H); 3.1-
~`~` . 3~ (m, 6H, SCH2 and 4 cyclopen-
tene H) 4~26 (s~ 3H~ NOCH3), 5.1-
6.Z ~m, 4H~ CH2Py and 2 lactam H~;
and 7~6-8.7 ppm (m, 3H, Py)
The compounds sho~n below, which correspond to
the general formula .

12;~9S4
25 -
C6115CO~ C13 (CH2) 3CONH~
~C~I2A
CO2
and ;n which A denotes the subst;tuent shown ;n the second
column of TabLe 1, are obtained ana~ogously to Example
4b (trimethyliodosilane method).
Table 1
Ex- A Yield 1H-NMR (CF3C02D): ~(ppm)
ample _ ~ of th.
13 ~ ~ 38 1.7-3.9 (m, 9H, SCH2, 7 pentane
-~ ~ H) 4.8-6.4 (m, 4H, CH2Py and
2 lactam H); 7.4-9.2 (m, 10H, Py '
and phenyl)
~ ' .
14 ~ ~ 22 1.7-3.9 (m, 9H, SCH2 and 7 pen-
tane H): 4.8-6.3 (m, 4H, CH2Py
\> and 2 lactam H) 7~3-8.6 (m, 10H,
\~/ phenyl and quinoline) 8.9-9.4
(m, 2 quinoline H)
26 1.8-3.1 (m, 7H, pentane); 3.39
~ ~ and 3.82 (AB, J = 19~1Z, SCH2);
4.8-6.3 (m, 4H, CH2Py and 2 lac-
\~/ tam H); 7.3-8.7 (m, 11H, ohenyl
and ;soquinoline); 9.5-9.85 (m,
1 isoquinoline H)

`` lZ2~i954
- 26 -
Ex- A Yield 1H-NMR (Cf3C02D): ~ ~ppm)
ample % of th
_ ........... __ _
16 ~ 32 1.6-4.1 (m, 17H, 8 cyclohexene
H, 7 pentane H and SCH2), 4.9-
6.4 (m, 4H, CH2Py and 2 lactam
-~ ~ H); 7.3-9.0 ~m, 8H, phenyl and
. Py)
: _
17 35 1.7-3.0 (m, 7H, pentane); 2.76
(s, 3H, CH3); 3.65 and 3.73
~ C~33 (AB, J = 19 Hz, SCH2); 4.7-6.3
I ~ (m, 4H, CH2Py and 2 lactam H);
7.3-8.9 (m, 9H, phenyl and Py)
. ' _
18 62 1.8-2.9 (m, 7 pentane H); 3.42
. C~T~5 and 3.76 (AB, J = 19 Hz, SCH2);
4.9-6.4 (m, 4H, CH2Py and 2
lactam H); 7.3-9.25 (m, 14H,
: ~ phenyl and Py)
:
.
~ .
.

59
-- 27 --
The compounds shown beLow, wh;ch correspond to
the general formula
~L C~2CO~il ~S
L~L--C~I2A
CO ~
and ;n which A denotes the substituent shown in the sec-
ond column of Table 2, are obtained analogously to
Example 1b (trimethyliodosilane method).
Table 2
Ex- A ¦Yield 1H-NMR (CF3C02D): ~ (ppm
ampl~ ¦% of th.
19 ~ 84 2.66 (s, 3H, CH3); 3.40 and
C~ 3.72 (AB, J = 19 Hzf 2H, SCH2);
4.06 (s, 2H, CH2C0); 5~05~6.40
: : ~ (m, 4H, CH2Py and 2 lactam H);
. ~ ~ ~ 6.8-7.4 (m, 3H, thiopene), 7.95-
: : ~ 9.20 (m, 4H, Py)
__ _ ~
3.38 and 3.72 (AB, J = 19 Hz,
C ~ SCH2); 4.10-(s, 2H, CH2C0);
~._ . 4.9-6.3 (m, 4H, CH2Py and 2 lac-
C~ tam H); 6.9-7.3 (m, 3H, thio-
~ ~ pene); 7.66 (s, 5H, phenyl);
: : 8.0-9.4 (m, 4H, Py)
"
.
.
~.

^ ~LZZ~ii954
-- 28 --
Ex- A ¦Yield 1H-NMR (CF3C02D): ~ (ppm)
ampl~e '~ of th.
- 21 ~ 35 1.7-2.4 (m, 4H, cyclohexene H);
2.8-3.8 (m, 6H, 4 cycLohexene H),
-~ ~ SCH2); 4.05 (s, 2H, CH2C0);
5.15-6.25 (m, 4H, CH2Py and
. 2 lactam H); 6.8-7.5 (m, 3H,
¦ th;opene); 7.6-8~8 (m, 3H, Py)
. . _ ~
; 22 ~ 38 3.40 and 3.78 (AB, J = 19 Hz,
2H, SCH2); 4.08 (s, 2H, CH2CO);
5.15-6.35 (m, 4H, CH2Py and
2 lactam H); 6.8-7.4 (m, 3H
thiopene); 7.9-8.8 (m, 6H,
isoqu;noline H); 9.5-9.8 (m,
1 soqu;noline H)
.. . . __ . ..... ~
23 Ci ~ 28 3.42 and 3n75 (AB, ~ = 19 Hz,
~1 ~ SCH2); 4.06 (s, 2H, CH2C0);
5.26-6.42 (m, 4H, CH2Py and
2 lactam H); 6.8-7.4 (m, 3H,
.
thiopene); 8.0-9.2 (m, 5H, Py)
: ~

~ 2~;9S4
-- 29 --
The compounds shown below, whir,h correspond to
the general formula
and in wh;ch R1 and R3 deno'ce the substi'cuents given
in Table 3, are obta;ned analogously to Example 1b (tri-
methyliodosilane method).
.
Table 3
Ex- R1 R3 Yield l1H-NMR (CF3COZD): ~(PPm)
ample % of th.
_
24 H ~ ~ 28 2.1-2.9 (m, SH, CH3-
S~H - s;ng. at 2.33 and
N 2 2 cyclopentene H); 3.1-
3.9 (m, 6H, SCH2 and
4 cyclopentene H); 4.03
(S, 2H, CH2CO); 5.15-
6.25 (m, 4H, CH2Py and
2 lactam H); 7.3-8.7
~ I r (m, SH, Py and imidazole)
H CNCH2- 32 2.1-2.9 (m, 2 cyclopen-
tene H); 3.1-3.8 (m, 6H, -!
. SCH2 and 4 cyclopentene H);
3.88 (S, 2H, CH2CO3; 5.2-
6.25 (m, 4H, CH2PY and
2 lactam H); 7.65-8.7
(m, 3H, PY)
- - - - -
: : :

2sgs~ ~
- 30 -
Ex- R1 R3 Yield 1N-NMR (CF3C02D): ~S(PPm)
ample X of th.
26 H ~ 68 2.2-2.9 ~m, Z cyclopen-
~ 11 tene H); 3.15-3.85 (m, 6H,
N SCH2 and 4 cyclopentene H);
OC}13 5.2-6.Z5 (rn, 4H, CH2Py
. . and 2 lactam H); 6.60;
6.98 and 7.57 (one
. furan H each); 7.6-8.7
. . . ~m, 3H, Py)
_
27OCH3 ~ I 65 2.2-2.9 (m, 2 cyclopen-
CO tene H); 2.9-3.8 (m, 6H,
SCH2 and 4 cyclopentene
. H); 3.70 (s, 3H, OCH3);
4.10 (s, 2H, CH2CO);
5.25-6.20 (m, 4H, CH2Py
. and 2 lactam H); 6.7-
7.45 (m, 3 thiopene H);
~ : ~ ~.65-8.7 tm, 3H, Py)
' ,
.
.
` -

~ 2~s4
- 31 -
End products
Example 1
7-Am;no-3-C2,3-cyclopenteno-1-pyr;d;n;o)methyl]~ceph~3~
em-4 carboxylate
a) Chem;caL spl;ttin~
- 5~6 ml (44 mmol) of N,N-d;rnethylan;l;ne and 2.8 ml
~22.2 rnmol~ of trimethylchlorosilane are added to a stir-
red suspension of 5~6 g (10.5 mmol) of 3-C(2,3~cyclopen-
teno-1-pyr;d;n;o)methyl~-7-(2-thienylacetam;do~-ceph-3-
ern-4-carboxylate hydro~hiocyanate salt (Example 1) in 40 ml
of dry methylene chloride. When the temperature is in-
creased slightly to 27C, a clear solution is formed.
After the mixture has been stirred at room temperature
for 1 hour, it is cooled to -40C and 4.6 g (22.2 mmol)
of PCl5 are added all at once, whereupon the tempera-
ture r;ses to -25C. The dark brown solution is stir-
red at -30C for 1 hour and is then poured into a solu-
- t~on, cooled to -40C, of 9 ml of ;sobutanol in 18 rnl
of methy;lene chloride. A precipitate formsO After the
mixture has been left to stand overnight in a refriyera-
; tor, the precip;tate is f;ltered off w;th suction and
washed with methylene chloride. The rnoist crude product
is immed;ately dissolved in 15 ml of methanol of -5C,
and 80 ml of methylene chloride:ether ~1:1) are added drop-
wise~ After stlrring at -10C for 2 hours, the precipi-
tate formed is filtered off ~ith suction, washed with
acetone and dried over PzO5 in vacuo.
Yield: 3c3 g (78% of theory) of Light brown crystals.
16H17N33S x 2 HCl
.

2~g~4
- 3Z -
Calculated: C 47.41 H 4.97 Cl 17.49 N 10.37X
Found: C 46.2 H 5.6 Cl 16.6 N 9.8%
IR (Ksr): 1785 cm -1 (lactam CO)
1H-NMR(CF3C02D): ~ = 2~55-2.95 ~m, 2H cyclopentene H);
3.15-3.95 (mf 6H, 4 cyclopen-
tene H and S-CHz); 5~53 (s,
2H, lactam H); 5.55 and 6.03
(AB,J - 15 Hz, 2H~ CH2Py),
7.65-8.70 ppm (m, 3H, Py).
10 b) Enzymatic splitting
106 y (0.2 mole) of 3-C(2,3-cyclopenteno~1-pyri~
d;n;o)methyl~-7-(2-th;enyl-acetamido)-ceph~3-em 4-car-
boxylate hydrothiocyanate salt (Example 1) are suspended
;n 6CO ml of water, a solution of 150 ml of Amberl;te LA-2
.
(Rohm and~Haas) in 800 ml of ethylacetate are added and
; the mixture ;s stirred in an ice-bath for half an hour.
The phases are sPparated and the aqueous solution is ex-
tracted~w;th two 50 ml portions of LA-2 (acetate forrn) in
150 ml of methyl isobutyl ketone and the extract is also
washed with four 100 ml portions of methylene chloride.
The aqueous phase is made up to a volume of 500 ml and
adjusted to pH 7 with NaHC03 tO.2 g). 100 9 of fixed
pen;c;llin G am;nohydrolase enzyme are added and the mix-
ture is stirred at 37C and pH 7.1. The pH value is
; 25 kept constant by dropwise addition of 1N NaOH. After
2 hours, 90 per cent conversion is achieved (thin layer
chromatography system: acetone/H20 - 5:1, silica ~el plates)~
The fixed enzyme is filtered off and washed with three
100 ml portions of water and the aqueous phases are brought

~ 122~954
-- 33 --
to pH 6 ~ith 2N HCL and freeze-dried. The amorphous
lyoph;l;sate ;s stirred w;th 250 ml of methanol, a small
amount of unsoluble mater;al is filtered off and 300 ml
of 15 percent strength alcoholic hydrochloric acid and
S then 1 l;ter of ether are added to the f;ltrate. After
2 hours at 0C, this precipitate is filtered off with
suction, washed with ether:methanol ~4:1~ and dried in
vacuo.
Yield: 61 g of colorless product (75% of theory). The com-
pound is identical ;n all its properties to that
descr;bed above in Example 1a.
The compounds of the general formula I l;sted inthe following Table 4 are obtained from the corresponding
2-thienylacetamido-cephalosporine der;vat;ves analogously
15 to Example 1 (method a: chemical spl;tting; method b: en-
zymatic splitting).
:
Table 4
Ex- A ¦Method Yield ~ 1H-NMR(CF3C02D): ~(ppm)
; ample 1- ~ of th~
2 ~ ¦ a(b)72 1.7-2.4 (m, 4H, cyclo- 3
. ~ hexene H); 2.7-3~95 (m,
(69) 6H, 4 cyclohexene H and
. ~ SCH2); 5~35-6.25 (m,
4H, CH2Py and 2 lactam
_ _ H), 7.75-8 65 (m, 3H, Py)
.
,' .

-- ~X2~;95~
- 34 -
Ex- A Method Yield 1H-NMR(CF3C02D): ~(ppm)
ample % of th.
.
3 ~_~ 3 a (b) 81 2.69 (s, 3H, CH3);
(78) 3.66 (s, 2H, SCH2);
5.25 6.39 (m, 4H,
CH2Py and 2 lactam H);
7.83-9.03 (m, 4 Py H)
... _ .. ___
4 ~ a (b) 77 3.4-3.9 (AB, 2H, SCH2);
~ (75) 5.2-6.4 ~m, 4H, CH2Py
-~ 9 and 2 lactam H); 7.9-
8.8 (m, 5 q~;nol;ne H);
8.85-9.2 (mJ2 qu;no-
l;ne H)
_~ .. .. ~ _
~ a (b) 80 3.5-4.0 (AB, 2H, SCH2);
-N ~ ~ J 5.1-6.6 (m, 4H, CH2Py
(74) and 2 lactam H); 7.9-
8.8 (m, 6 ;soqu;noline
H); 9.8-9.95 (bs, 1 ;so-
qu;nol;ne H)
. _ ~. _
:
: ~ :
::
:
:` :

-` ~L225!9S4
- 35 -
Example 6
7-Amino-3-(2,3-cyclopenteno-1-pyrid;n;o)methyl-ceph-3-
em-4-carboxylate
-
3 9 (5.2 mmole) of 7-(D-5-benzamido-5-carboxypen-
S tanamido)-3-(2,3-cyclopenteno-1-pyridinio)methyl-ceph-3
em-4-carboxylate (Starting Example 4) are suspended in
20 ml of methylene chloride. After addition of 3.9 ml
(31.2 mmole) of N,N-dimethylaniline and 3.9 ml (31.Z mmole)
of trimethylchlorosilane, the mixture is stirred at room
temperature for 1 hour. The clear solu~ion is cooled to
40C and 6.2 g (30 mmole) of PCl5 are added~ The solu-
tion ;s stirred at -30 for 1 hour and is then poured,
all at once, into a solution, cooled to -40C, of 4.1 ml
of isobutanol in lO ml of methylene chloride. The mix-
ture ;s left at 0 for 1 hour and the solvent is thenremoved in a rotary vacuum evaporator. The res;due is
d;ssolved in 5 g of ;ce-water and the solution is brought
to pH 6 by addition of NaHC03O It is chromatographed
over~a silica gel column using acetone:~ater (2:1). The
product fract;ons are fre~eze-dried.
Y;eid: 0.83 g (48% of theory)
H-NMR ~CF3C02D): ~ ~= 2.2-2.9 (m, 2H, cyclopentene
H); 3.15-3.93 (m, 6H, 4 cyclopen-
tene H and SCH2); 5.25 6.35 (m,
4H, CH2Py and 2 lactam H); 7.65-
8.0 (m, 1H, Py); 8.23-8~7 ppm (m,
2H, PY)
~he compound of Example 6 is obtained from the
. '
.

LX2S9S4
- 36 -
benzenesulfonamido compounds o~ startlng Examples 6, 7 and
8, ;n a manner analogous to that descr;bed ;n Example 6.
Y;eld: 55% from the compound of starting Example 6
62% from the compound of starting Example 7
58% from the compound of start;ng Example 8
The compound obtained in each case is ;dent;cal
in all its properties to that describe~d above in Example 6.
Example 6
a) 3-~(2,3-Cyclopenteno-1 pyridin;o)methyl]-7-for-
-
~ mylamino-ceph-3-em-4-carboxylate hydriodide
24 g (0.08 mole) of anhydrous 7-formyl-am;no
cephalosporanlc acid are suspended in 400 ml of dr;ed
methylene chloride, and 46~8 ml (0~4 mole) of cyclopen-
tenopyr;~dlne are added at room temperature. 45.6 ml
(0.32 mole) of trimethylsilyl iodlde are added dropwise
to the clear solution, ~Ihile stirriny and wi.h exclusion
of mo;sture, and the m;xture is heated under refLux for
two hours. Tbe reaction mixture is then cooled to 0C,
2ûO ml of water are added and tl1e mixture is neutralized
w;th about 400 ml of saturated sodium bicarbonate solutlon
~pH 6). The phases are separated and the organ;c phase
;s extracted by shaking with 80 ml of water. The comb;ned
aqueous phases are extracted with three 200 ml portions
; of methylene chloride and separated off, residues of
methylene chloride are removed from the aqueous phase in
vacuo and the aqueous phase is clar;fied with 4 g of
-~ act;ve charcoal. The filtered a~ueous solution is brought
to a pH value of about 1~5 with 200 ml of 1N HI and is
then concentrated to about 100 ml in vacuo on a rotary
,

2595A
-- ~i7 --
evaporator The prec;pitate is filtered off with suction,
~Jashed w;th acetone and dr;ed ;n vacuo over P20
Yield: 24.1 9 (59.6% of theory)
cl7ti17N304XHIXH20 (505 3)
Calculated: C 40.41 H 3.99 I 25.11 N 8.32 S 6.35 H20 3.56X
Found: C 40.1 H 4.1 I Z3O7 N 8.2 S ~.4 H20 4.2%
H-NMR (CF3)C02)D: aS = 2.3-2.8 ~m, 2H, cyclopen
tene H); 3.15-3.~5 (m, 6H, 4
cyclopentene H and SCH2); 5.25-
6.30 (m, 4H, CH2Py and Z lac-
tam H~; 7.65-8 75 tm, 4H, HC0
and 3 Py H)
b) 7~-hmino-3-~(Z,3-cyclopenteno-1~pyr;din;o)methyl]-
ceph 3-em-~-carboxylate
,
15 D;hydrochloride
20.2 g (0.04 mole~ of the product of Stage a are
suspended ;n 200 ml of 2N hydrochloric acid. The suspen-
s;on ;s warmed to ~60C, a cLear solution be;ng formed,
and the soLution ;~5 lef~ at th;s temperature for a fur~
20 ther S~ minutes. It is concent~rated to a volume of about
40 ml on a rotary vacuum evaporator. After addit;on of
120 ml of acetone, the dihydrochloride of the title com-
pound precipitates as crystals. The crystals are filtered
otf witl1 suction, washed with acetone and dried in vacuo
over P205.
Y;eld: 15.4 g ~B6% of theory~, decomposition 167C
C16H17N303S x 2 HCl x H20 (422~4)
Calculated: C 45.5 H 5.0 Cl 160~ N 9.9 H20 4.3%
Found: C 44~0 H 4~8 Cl 15.2 N 9~6 H20 3O3%

5954
~ .
The N.~R spectrum is identical in all its proper-
t;es to that of Example 1a.
-Monohydr;od;de and monohydrochloride
. 0.422 g (1 mmole) of the above dihydrochloride is
dissolved ;n 2 ml of water at room temperature. 84 mg of
sodium b;carbonate and 0.05 ml ~about 0.4 mmole) of 57 per
cent hydriodic acid are added. The mo.nohydriodide preci-
p;tates from the clear solut;on as crystal. The crystals
are f;ltered off w;th suct;on~ washed with a l;ttle water
10 and dried in vacuo over H2S04.
Yield 0-2 y
C16H17N33S x HI x H20 (4773)
Calculated: C 1~0.26 H 4.22 I 26.59 N 8.80%
Found: ~C 40.7 H 4.2 I 25.0 N 8.9%
The monochloride is obtained from the mother
~l;qor by adding~acetone until crystaLlization starts.
The crystallization of 200 mg from acetone: water (6:1)
gives 130 mg of pure monochloride monohydrate.
16H17N33S x HCl x H20 (385.9)
Calculated: C 49.80 H 5.22 Cl 9.18 N 10.89 S 8.31%
.
Found: C 50.1 H 5.6 Cl 8.8 N 10.9 S 8.9%
.
~, .
~ '
:` '
.
,
. .

Representative Drawing

Sorry, the representative drawing for patent document number 1225954 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: Expired (old Act Patent) latest possible expiry date 2004-08-25
Grant by Issuance 1987-08-25

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
HOECHST AKTIENGESELLSCHAFT
Past Owners on Record
REINER KIRRSTETTER
RUDOLF LATTRELL
WALTER DURCKHEIMER
WILFRIED SCHWAB
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 1994-01-30 3 78
Abstract 1994-01-30 1 12
Drawings 1994-01-30 1 32
Descriptions 1994-01-30 37 1,063